By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Food and Drug Administration (FDA) 

5600 Fishers Lane

Rockville  Maryland  20857  U.S.A.
Phone: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332) Fax:

FDA Overview:

The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.

•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.

FDA's Mission Statement

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.

Key Statistics

Ownership: Private

Web Site: FDA


Company News
Optovue, Inc.'s AngioVue Imaging System Receives FDA Clearance 2/12/2016 9:55:10 AM
Clovis Oncology (CLVS) Announces Rociletinib New Drug Application Scheduled For Presentation At Upcoming FDA Oncologic Drugs Advisory Committee Meeting 2/12/2016 8:02:06 AM
Zimmer Biomet Announces FDA Clearance for Unite3D Bridge Fixation System 2/12/2016 6:03:19 AM
Kindred Bio (KIN) Submits Zimeta (KIND-012) New Animal Drug Application Technical Section For Effectiveness To FDA 2/12/2016 6:01:13 AM
ONL Therapeutics Receives Orphan Drug Designation For ONL1204 For Treatment Of Retinal Detachment From FDA 2/11/2016 10:30:24 AM
Cellceutix (CTIX) Meets With FDA For Phase 2 Clinical Trial Of Kevetrin For Ovarian Cancer 2/11/2016 10:19:45 AM
Guerbet (GBT) Grabs FDA Nod for the OptiOne Single-Head Contrast Delivery System 2/11/2016 6:42:04 AM
Lannett (LCI) Receives FDA Approval For Temozolomide Capsules 2/11/2016 6:27:55 AM
FDA Green Lights MX Orthopedics' Dynamx Compression Staple 2/11/2016 6:21:34 AM
Wenzel Spine Snags FDA Approval to Launch VariLift-LX 2/11/2016 5:53:39 AM